Dextran-magnetite particles: Contrast-enhanced MRI of blood-brain barrier disruption in a rat model

Jeff W Bulte, M. W A De Jonge, R. L. Kamman, K. G. Go, F. Zuiderveen, B. Blaauw, J. A. Oosterbaan, T. H. The, L. De Leij

Research output: Contribution to journalArticle

Abstract

Dextran-magnetite particles (DMP) were studied for their use as a MR contrast agent to visualize lesions with a blood-brain barrier (bbb) disruption. A freezing injury to the rat cerebral cortex was used as a model of bbb disruption. The biodistribution of iv-injected DMP was studied using atomic absorption spectrophotometry, electron microscopy, and MRI. One hour after injection, focal accumulation of the particles in capillary endothelial cells could be demonstrated in the freezing lesion. Despite the observation that the relaxivity of DMP in vivo appears to be less well pronounced than that in vitro, the MR imaging studies show that DMP can be used to visualize bbb disruption with adequate contrast.

Original languageEnglish (US)
Pages (from-to)215-223
Number of pages9
JournalMagnetic Resonance in Medicine
Volume23
Issue number2
StatePublished - 1992
Externally publishedYes

Fingerprint

Ferrosoferric Oxide
Dextrans
Blood-Brain Barrier
Freezing
Atomic Spectrophotometry
Cerebral Cortex
Contrast Media
Electron Microscopy
Endothelial Cells
Injections
Wounds and Injuries

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Bulte, J. W., De Jonge, M. W. A., Kamman, R. L., Go, K. G., Zuiderveen, F., Blaauw, B., ... De Leij, L. (1992). Dextran-magnetite particles: Contrast-enhanced MRI of blood-brain barrier disruption in a rat model. Magnetic Resonance in Medicine, 23(2), 215-223.

Dextran-magnetite particles : Contrast-enhanced MRI of blood-brain barrier disruption in a rat model. / Bulte, Jeff W; De Jonge, M. W A; Kamman, R. L.; Go, K. G.; Zuiderveen, F.; Blaauw, B.; Oosterbaan, J. A.; The, T. H.; De Leij, L.

In: Magnetic Resonance in Medicine, Vol. 23, No. 2, 1992, p. 215-223.

Research output: Contribution to journalArticle

Bulte, JW, De Jonge, MWA, Kamman, RL, Go, KG, Zuiderveen, F, Blaauw, B, Oosterbaan, JA, The, TH & De Leij, L 1992, 'Dextran-magnetite particles: Contrast-enhanced MRI of blood-brain barrier disruption in a rat model', Magnetic Resonance in Medicine, vol. 23, no. 2, pp. 215-223.
Bulte, Jeff W ; De Jonge, M. W A ; Kamman, R. L. ; Go, K. G. ; Zuiderveen, F. ; Blaauw, B. ; Oosterbaan, J. A. ; The, T. H. ; De Leij, L. / Dextran-magnetite particles : Contrast-enhanced MRI of blood-brain barrier disruption in a rat model. In: Magnetic Resonance in Medicine. 1992 ; Vol. 23, No. 2. pp. 215-223.
@article{3417252d0e5648219a03ff49dcc1155c,
title = "Dextran-magnetite particles: Contrast-enhanced MRI of blood-brain barrier disruption in a rat model",
abstract = "Dextran-magnetite particles (DMP) were studied for their use as a MR contrast agent to visualize lesions with a blood-brain barrier (bbb) disruption. A freezing injury to the rat cerebral cortex was used as a model of bbb disruption. The biodistribution of iv-injected DMP was studied using atomic absorption spectrophotometry, electron microscopy, and MRI. One hour after injection, focal accumulation of the particles in capillary endothelial cells could be demonstrated in the freezing lesion. Despite the observation that the relaxivity of DMP in vivo appears to be less well pronounced than that in vitro, the MR imaging studies show that DMP can be used to visualize bbb disruption with adequate contrast.",
author = "Bulte, {Jeff W} and {De Jonge}, {M. W A} and Kamman, {R. L.} and Go, {K. G.} and F. Zuiderveen and B. Blaauw and Oosterbaan, {J. A.} and The, {T. H.} and {De Leij}, L.",
year = "1992",
language = "English (US)",
volume = "23",
pages = "215--223",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Dextran-magnetite particles

T2 - Contrast-enhanced MRI of blood-brain barrier disruption in a rat model

AU - Bulte, Jeff W

AU - De Jonge, M. W A

AU - Kamman, R. L.

AU - Go, K. G.

AU - Zuiderveen, F.

AU - Blaauw, B.

AU - Oosterbaan, J. A.

AU - The, T. H.

AU - De Leij, L.

PY - 1992

Y1 - 1992

N2 - Dextran-magnetite particles (DMP) were studied for their use as a MR contrast agent to visualize lesions with a blood-brain barrier (bbb) disruption. A freezing injury to the rat cerebral cortex was used as a model of bbb disruption. The biodistribution of iv-injected DMP was studied using atomic absorption spectrophotometry, electron microscopy, and MRI. One hour after injection, focal accumulation of the particles in capillary endothelial cells could be demonstrated in the freezing lesion. Despite the observation that the relaxivity of DMP in vivo appears to be less well pronounced than that in vitro, the MR imaging studies show that DMP can be used to visualize bbb disruption with adequate contrast.

AB - Dextran-magnetite particles (DMP) were studied for their use as a MR contrast agent to visualize lesions with a blood-brain barrier (bbb) disruption. A freezing injury to the rat cerebral cortex was used as a model of bbb disruption. The biodistribution of iv-injected DMP was studied using atomic absorption spectrophotometry, electron microscopy, and MRI. One hour after injection, focal accumulation of the particles in capillary endothelial cells could be demonstrated in the freezing lesion. Despite the observation that the relaxivity of DMP in vivo appears to be less well pronounced than that in vitro, the MR imaging studies show that DMP can be used to visualize bbb disruption with adequate contrast.

UR - http://www.scopus.com/inward/record.url?scp=0026500624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026500624&partnerID=8YFLogxK

M3 - Article

C2 - 1372384

AN - SCOPUS:0026500624

VL - 23

SP - 215

EP - 223

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 2

ER -